n-methyl-3,4-methylenedioxyamphetamine and Clerambault Syndrome studies

n-methyl-3,4-methylenedioxyamphetamine and Clerambault Syndrome

N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.

Research Excerpts

Excerpt	Relevance	Reference
" Many studies introduce statistical errors by inconsistently dichotomizing and comparing light and heavy ecstasy users, making dose-response relationships inconclusive."	2.61	The spurious relationship between ecstasy use and neurocognitive deficits: A Bradford Hill review. ( Amoroso, T, 2019)

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (50.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	0 (0.00)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

0 (0.00)

18.7374

1990's

2 (50.00)

18.2507

2000's

1 (25.00)

29.6817

2010's

1 (25.00)

24.3611

2020's

0 (0.00)

2.80

Authors

Authors	Studies
Amoroso, T	1
Parrott, AC	1
Milani, RM	1
Gouzoulis-Mayfrank, E	1
Daumann, J	1
Franck, N	1
Bertrand, J	1
Creighton, FJ	1
Black, DL	1
Hyde, CE	1

Studies

Amoroso, T

Parrott, AC

Milani, RM

Gouzoulis-Mayfrank, E

Daumann, J

Franck, N

Bertrand, J

Creighton, FJ

Black, DL

Hyde, CE

Reviews

3 reviews available for n-methyl-3,4-methylenedioxyamphetamine and Clerambault Syndrome

Article	Year
The spurious relationship between ecstasy use and neurocognitive deficits: A Bradford Hill review. The International journal on drug policy, 2019, Volume: 64 Topics: Cognition; Databases, Bibliographic; Drug-Related Side Effects and Adverse Reactions; Humans; Memory	2019
Cannabis and Ecstasy/MDMA (3,4-methylenedioxymethamphetamine): an analysis of their neuropsychobiological interactions in recreational users. Journal of neural transmission (Vienna, Austria : 1996), 2007, Volume: 114, Issue:8 Topics: Animals; Cannabis; Cytoprotection; Drug Interactions; Fever; Hallucinogens; Humans; Marijuana Abuse;	2007
[Ecstasy: from recreational drug to toxic substance]. Revue medicale de Liege, 1997, Volume: 52, Issue:11 Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Amphetamines; Animals; Biochemical Phenomena; Bioch	1997

Article

Year

The spurious relationship between ecstasy use and neurocognitive deficits: A Bradford Hill review.

The International journal on drug policy, 2019, Volume: 64

Topics: Cognition; Databases, Bibliographic; Drug-Related Side Effects and Adverse Reactions; Humans; Memory

2019

Cannabis and Ecstasy/MDMA (3,4-methylenedioxymethamphetamine): an analysis of their neuropsychobiological interactions in recreational users.

Journal of neural transmission (Vienna, Austria : 1996), 2007, Volume: 114, Issue:8

Topics: Animals; Cannabis; Cytoprotection; Drug Interactions; Fever; Hallucinogens; Humans; Marijuana Abuse;

2007

[Ecstasy: from recreational drug to toxic substance].

Revue medicale de Liege, 1997, Volume: 52, Issue:11

Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Amphetamines; Animals; Biochemical Phenomena; Bioch

1997

Other Studies

1 other study available for n-methyl-3,4-methylenedioxyamphetamine and Clerambault Syndrome

Article	Year
'Ecstasy' psychosis and flashbacks. The British journal of psychiatry : the journal of mental science, 1991, Volume: 159 Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Adult; Delusions; Euphoria; Female; Humans; Male; Mental	1991

Article

Year

'Ecstasy' psychosis and flashbacks.

The British journal of psychiatry : the journal of mental science, 1991, Volume: 159

Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Adult; Delusions; Euphoria; Female; Humans; Male; Mental

1991